The aims of the Levosimendan for the Prevention of Acute oRgan Dysfunction in Sepsis ( LeoPARDS ) trial are to identify whether a 24-hour infusion of levosimendan will improve organ dysfunction in adults who have septic shock and to establish the safety profile of levosimendan in this group of patients .